Status:
UNKNOWN
Immune Response Following COVID-19 Vaccination
Lead Sponsor:
Texas Cardiac Arrhythmia Research Foundation
Conditions:
IgM and IgG in Blood
Eligibility:
All Genders
16-85 years
Brief Summary
Few trials have reported the safety and efficacy of the COVID-19 vaccines. However, these trials were mostly focused on post-vaccination adverse events and short-term antibody detection with none moni...
Detailed Description
The COVID-19 pandemic started in December 2019 and since then has spread globally claiming over 550, 000 deaths, \>12 million infections and an economic toll in the trillions of dollars to date. The u...
Eligibility Criteria
Inclusion
- • Individuals that have received first dose of COVID-19 vaccine
Exclusion
- Unwilling to provide informed consent
- Unwilling for the follow-up serological test during the 1-year enrollment
Key Trial Info
Start Date :
January 15 2021
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
March 1 2022
Estimated Enrollment :
500 Patients enrolled
Trial Details
Trial ID
NCT04736524
Start Date
January 15 2021
End Date
March 1 2022
Last Update
February 3 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Texas Cardiac arrhythmia Institute, St. David's Hospital
Austin, Texas, United States, 78705